HQY stock is down more than 13% YTD amid cyber threats and rising costs, but strong HSA fundamentals remain. Is it time to hold or fold? Let's break it down.

What is this about: On March 19, 2025, during market hours, Investopedia published an article entitled “HealthEquity Stock Plummets as Firm’s Profit Hurt by Cyber Threats, Fraud.” ...

Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho started ...

Bank of America double-upgraded PLTK to "buy" from "underperform" Playtika (NASDAQ:PLTK) stock is heading for its best session on record today, after Bank of America issued a rare double-upgrade ...

Raymond James sees the underlying fundamentals and strategic positioning of HealthEquity as strong, and believes the stock’s current levels offer an attractive opportunity for long-term investors, ...

Raymond James upgraded HealthEquity (HQY) to Strong Buy from Outperform with a price target of $115, down from $120. The firm upgrade the ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS ... VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,744K shares ...

Ultratech Cement share price surged as much as 3.20 per cent on Tuesday's trading session after global brokerage firm UBS upgraded the stock to ‘buy’. At 10:30 am, Ultratech Cement stock was ...

HealthEquity stock’s recent year-to-date underperformance is partly due to its disclosure of fraud against some of its HSA customers and near-term investor concerns about recent management changes.